Loading...
The Healf Source
Healf Named UK’s #2 Fastest-Growing Company By The Sunday Times
The company made its debut on the Sunday Times' list after hitting an annual sales growth of 434.11% over three consecutive years.
Written by: Healf
Written on: June 26, 2025
June 27, 2025
Healf was recognised today as the UK’s second-fastest growing company by The Sunday Times after hitting an annual sales growth of 434.11% over three consecutive years.
“Healf’s debut at #2 on The Sunday Times’ list is a powerful reflection of the momentum behind a new era of personalised wellbeing,” said Healf co-founder and CEO, Lestat McCree. “We believe wellbeing should be inspiring and energising — elevating how you feel every day. What’s driving our growth isn’t just appetite for better products, but alignment with a more intentional way of living. We’re not simply scaling a company, we’re driving a cultural shift.”
The list, which has been ranking the top 100 private UK companies with the highest annual sales growth for four years now, previously recognised companies like TRIP (2023), the hugely popular CBD-infused drinks brand, and Bloom & Wild (2022), which is now the largest direct-to-consumer flower business in Europe. Other alumni include fashion brand Me+Em (2022, 2023), which opened a new flagship store in LA this January, and pizza oven-maker Ooni (2022, 2023), which marked £750 million in sales and nearly 3 million ovens sold globally in September.
With thousands of wellbeing products that have been carefully vetted and selected by Healf’s curation team on site — from electrolytes to supplements, high-tech wearables, clean skincare, and recovery tech — the company is poised to meet the exploding demand this year and continues to shape a new narrative around health and wellbeing that centres on intuition, personalised data, and prevention.
You can read the full report from The Sunday Times here.
This article is for informational purposes only, even if and regardless of whether it features the advice of physicians and medical practitioners. This article is not, nor is it intended to be, a substitute for professional medical advice, diagnosis, or treatment and should never be relied upon for specific medical advice. The views expressed in this article are the views of the expert and do not necessarily represent the views of Healf
